The SC cell line as an in vitro model of human monocytes

J Leukoc Biol. 2022 Oct;112(4):659-668. doi: 10.1002/JLB.1A1221-680R. Epub 2022 Mar 31.

Abstract

In vitro analysis of human macrophages is generally hampered by the necessity to differentiate them from peripheral blood monocytes. We have analyzed to which extent noncancerous SC monocytes could be used as an in vitro macrophage model. Macrophages differentiated from peripheral monocytes using standard CSF1 and CSF2 protocols for M2 and M1 precursors, respectively, were compared with THP-1-derived macrophages treated with PMA and with SC-derived macrophages differentiated either by CSF1, CSF2, or PMA according to different protocols. The optimal condition for generation of SC macrophages was treatment with PMA for 3 days, followed by 5-days culture without PMA and 24-h polarization with LPS/IFN-γ or IL-4/IL-13. Similar to THP-1, SC cells do not express the monocyte marker CD14 and differentiation to macrophages results neither in CD68 nor in CD14 expression, both of which were expressed by monocyte-derived macrophages. Similar to THP-1-macrophages, a proportion of SC macrophages can be polarized to the M1-like subtype that is characterized by higher expression of CD38, CD86, CD80, TNF-α, and IL-1ra, whereas treatment with IL4/IL13 did not lead to expression of the M2-associated receptors CD163, CD206, and only slightly increased the CD200R expression. Still, SC-M1 express much lower levels of the M1-associated markers compared with monocyte-derived M1 and no IL-1β. The data demonstrate that SC-derived macrophages differ from monocyte-derived macrophages in respect of their morphology, expression of important macrophage markers, phagocytosis. Yet, polarized SC-M1-like cells may with restrictions serve as a model for M1 macrophages, though this model does not provide significant advantages over already well-described THP-1-M1-like cells.

Keywords: SC monocytes; macrophage differentiation; macrophage polarization; macrophage polarization markers; monocyte-derived macrophages; monocytes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers / metabolism
  • Cell Differentiation
  • Cell Line
  • Humans
  • Interleukin 1 Receptor Antagonist Protein / metabolism
  • Interleukin-13* / metabolism
  • Interleukin-4 / metabolism
  • Interleukin-4 / pharmacology
  • Lipopolysaccharides / metabolism
  • Lipopolysaccharides / pharmacology
  • Monocytes* / metabolism
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Biomarkers
  • Interleukin 1 Receptor Antagonist Protein
  • Interleukin-13
  • Lipopolysaccharides
  • Tumor Necrosis Factor-alpha
  • Interleukin-4